Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma
- 25 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 30 (11), 6339-6347
- https://doi.org/10.1007/s00330-020-06985-5
Abstract
Objective To investigate the value of pre-treatment amide proton transfer–weighted (APTw) imaging for predicting survival of patients with nasopharyngeal carcinoma (NPC). Materials and methods Pre-treatment APTw imaging was performed in 77 NPC patients and the mean, 90th percentile, skewness, and kurtosis of APT asymmetry (APTmean, APT90, APTskewness, and APTkurtosis, respectively) were obtained from the primary tumor. Associations of APTw parameters with locoregional relapse–free survival (LRRFS), distant metastasis–free survival (DMFS), and disease-free survival (DFS) after 2 years were assessed by univariable Cox regression analysis and significant APTw parameters, together with age, sex, treatment, and stage as confounding variables, were added to the multivariable model. Kaplan-Meier analysis was used to determine the prognostic significance of patients with high or low APT values based on a threshold value from receiver operating characteristic curve analysis. Results Locoregional relapse, distant metastases, and disease relapse occurred in 14/77 (18%), 10/77 (13%), and 20/77 (26%) patients, respectively, at a median follow-up of 48.3 (10.6–67.4) months. Univariable analysis showed significant associations of LRRFS with APTskewness (HR = 1.98; p = 0.034), DMFS with APTmean (HR = 2.44; p = 0.033), and APT90 (HR = 1.93; p = 0.009), and DFS with APTmean (HR = 2.01; p = 0.016), APT90 (HR = 1.68; p = 0.009), and APTskewness (HR = 1.85; p = 0.029). In multivariable analysis, the significant predictors for DMFS were APT90 (HR = 3.51; p = 0.004) and nodal stage (HR = 5.95; p = 0.034) and for DFS were APT90 (HR = 1.97; p = 0.010) and age (HR = 0.92; p = 0.014). An APT90 ≥ 4.38% was associated with a significantly poorer DFS at 2 years than APT90 < 4.38% (66% vs. 91%; HR = 4.01; p = 0.005). Conclusion APTw imaging may potentially predict survival in patients with NPC. Key Points • APTw imaging may provide new markers to predict survival in nasopharyngeal carcinoma. • APT90is an independent predictor of distant metastases–free survival and disease-free survival. • The APThighgroup is at higher risk of disease relapse than the APTlowgroup.Funding Information
- Research Grants Council, University Grants Committee (CUHK141070/14 and SEG_CUHK02)
This publication has 46 references indexed in Scilit:
- In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastomaProceedings of the National Academy of Sciences of the United States of America, 2014
- Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological gradesNeuro-Oncology, 2013
- Recurrent Glioblastoma: Optimum Area under the Curve Method Derived from Dynamic Contrast-enhanced T1-weighted Perfusion MR ImagingRadiology, 2013
- Three-Dimensional Turbo-Spin-Echo Amide Proton Transfer MR Imaging at 3-Tesla and Its Application to High-Grade Human Brain TumorsMolecular Imaging & Biology, 2012
- Adjuvant chemotherapy in advanced nasopharyngeal carcinoma based on plasma EBV loadJournal of Radiation Oncology, 2012
- Abstract P5-13-08: Factors Affecting Delivery of Planned Chemotherapy for Breast Cancer in Older WomenPublished by American Association for Cancer Research (AACR) ,2010
- Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brainMagnetic Resonance in Medicine, 2010
- Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic VarietyJournal of Clinical Oncology, 2005
- Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal CarcinomaJNCI Journal of the National Cancer Institute, 2005
- Amide proton transfer (APT) contrast for imaging of brain tumorsMagnetic Resonance in Medicine, 2003